Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling

Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling

Most pancreatic neuroendocrine tumors (PNETs) are indolent, while pancreatic ductal adenocarcinomas (PDACs) are particularly aggressive. To elucidate the basis for this difference and to establish the biomarkers, by using the deep sequencing, we analyzed somatic variants across coding regions of 409...

Full description

Bibliographic Details
Main Authors: Teresa Starzyńska, Jakub Karczmarski, Agnieszka Paziewska, Maria Kulecka, Katarzyna Kuśnierz, Natalia Żeber-Lubecka, Filip Ambrożkiewicz, Michał Mikula, Beata Kos-Kudła, Jerzy Ostrowski
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
neuroendocrine tumors
adenocarcinoma
NGS
mRNA
miRNA
somatic mutation
Online Access:https://www.mdpi.com/1422-0067/21/12/4470

Internet

https://www.mdpi.com/1422-0067/21/12/4470

Similar Items